Characteristics of validation cohort.

*There were no enough total RNA left for three SR patients because they were used for other miRNAs' validation; &With one year of clinical follow-up; ** There were no enough total RNA left for two patients without relapse because they were used for other miRNAs' validation; #There were no enough total RNA left for seven good response patients because they were used for other miRNAs' validation.

* 因3例SR患者的样本已用于其他微小RNA（miRNAs）的验证实验，故未留存足够的总RNA；& 所有患者均接受了为期1年的临床随访；** 因2例未复发患者的样本已用于其他微小RNA的验证实验，故未留存足够的总RNA；# 因7例治疗应答良好患者的样本已用于其他微小RNA的验证实验。